Patent US5216176A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5216176A Expired / Lapsed US ⏱️ 0.0 years remaining

7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor

Assignee: Nikon Corp
•
Filing: 1990-12-21
•
Granted: 1993-06-01
•
Expires: 2010-12-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A photochemotherapeutic compound of the formula <IMAGE> wherein (i) n is zero, W is a (C1-16) alkyl, alkenyl, or alkynyl linear or branched chain hydrocarbon, having no more than four O, N, or S atoms in or attached to the chain; or (ii) n is 1, W is CR or CR2, and R, R', and R'' are independently H or CH3; or (iii) N is 2, W is CR or CR2, and R, R', and R'' are independently H or CH3; and A, B, C, and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, aryloxy, hydroxy, carboxy, haloalkyl, or haloalkoxy, particularly compounds of the foregoing structure in which W is a charged substiuent and n=0 or 1.

Inventors

  • 👤 Ned D. Heindel
  • 👤 Michele C. Jetter nee Siller
  • 👤 Jeffrey D. Laskin
  • 👤 Michael A. Gallo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 15:38
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/02; C07D493/04

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 37 words
A photochemotherapeutic compound 4,8-dimethyl-7-(omega-carboxyheptyloxy) coumarin of the formula ##STR11## wherein W is (CH 2 ) 7 COOH; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 2
Dependent Claim 37 words
A photochemotherapeutic compound 4,8-dimethyl-7-(omega-carboxyheptyloxy) coumarin of the formula ##STR11## wherein W is (CH 2 ) 7 COOH; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 3
Dependent Claim 39 words
A photochemotherapeutic compound 4-methyl-8-iodo-7-(2-methyl-3-buten-2-yl)oxycoumarin of the formula ##STR12## wherein W is C(CH 3 ) 2 CH═CH 2 ; R 3 , R 5 and R 6 are hydrogen; R 4 is CH 3 ; and R 8 is I.
Claim 4
Dependent Claim 39 words
A photochemotherapeutic compound 4-methyl-8-iodo-7-(2-methyl-3-buten-2-yl)oxycoumarin of the formula ##STR12## wherein W is C(CH 3 ) 2 CH═CH 2 ; R 3 , R 5 and R 6 are hydrogen; R 4 is CH 3 ; and R 8 is I.
Claim 5
Dependent Claim 37 words
A photochemotherapeutic compound 7-(2-octyn-1-yl)oxycoumarin of the formula ##STR13## wherein W is CH 2 C.tbd.C(CH 2 ) 4 CH 3 ; and R 3 , R 4 , R 5 , R 6 and R 8 are hydrogen.
Claim 6
Dependent Claim 37 words
A photochemotherapeutic compound 7-(2-octyn-1-yl)oxycoumarin of the formula ##STR13## wherein W is CH 2 C.tbd.C(CH 2 ) 4 CH 3 ; and R 3 , R 4 , R 5 , R 6 and R 8 are hydrogen.
Claim 7
Dependent Claim 36 words
A photochemotherapeutic compound 4,8-dimethyl-7-ethoxycoumarin of the formula ##STR14## wherein W is CH 2 CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 8
Dependent Claim 36 words
A photochemotherapeutic compound 4,8-dimethyl-7-ethoxycoumarin of the formula ##STR14## wherein W is CH 2 CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 9
Dependent Claim 34 words
A photochemotherapeutic compound 4,8-dimethyl-7-methoxycoumarin of the formula ##STR15## wherein W is CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 10
Dependent Claim 34 words
A photochemotherapeutic compound 4,8-dimethyl-7-methoxycoumarin of the formula ##STR15## wherein W is CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 11
Dependent Claim 38 words
A photochemotherapeutic compound 4,8-dimethyl-7-butyloxycoumarin of the formula ##STR16## wherein W is (CH 2 ) 3 CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 12
Dependent Claim 38 words
A photochemotherapeutic compound 4,8-dimethyl-7-butyloxycoumarin of the formula ##STR16## wherein W is (CH 2 ) 3 CH 3 ; R 3 , R 5 and R 6 are hydrogen; and R 4 and R 8 are CH 3 .
Claim 13
Dependent Claim 71 words
A photochemotherapeutic compound of the formula: ##STR17## wherein W is selected from the group consisting of a C 1 to C 16 alkyl and alkenyl hydrocarbon chain substituted on said hydrocarbon chain with a polar functional moiety selected from the group consisting of hydroxyl, carboxyl and amino moieties; A, B, C, and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, aryloxy, hydroxy, carboxy, haloalkyl, or haloalkoxy.
Claim 14
Dependent Claim 71 words
A photochemotherapeutic compound of the formula: ##STR17## wherein W is selected from the group consisting of a C 1 to C 16 alkyl and alkenyl hydrocarbon chain substituted on said hydrocarbon chain with a polar functional moiety selected from the group consisting of hydroxyl, carboxyl and amino moieties; A, B, C, and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, aryloxy, hydroxy, carboxy, haloalkyl, or haloalkoxy.
Claim 15
Dependent Claim 87 words
A therapeutic agent having an extracellular activity on mammalian cells comprising a pharmaceutically acceptable carrier and a compound of the formula ##STR18## wherein W is selected from the group consisting of a C 1 to C 16 alkyl and alkenyl hydrocarbon chain permissively substituted on said hydrocarbon chain with a polar functional moiety selected from the group consisting of hydroxyl, carboxyl and amino moieties, and A, B, C and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, hydroxy, carboxy, haloalkyl or haloalkoxy.
Claim 16
Dependent Claim 87 words
A therapeutic agent having an extracellular activity on mammalian cells comprising a pharmaceutically acceptable carrier and a compound of the formula ##STR18## wherein W is selected from the group consisting of a C 1 to C 16 alkyl and alkenyl hydrocarbon chain permissively substituted on said hydrocarbon chain with a polar functional moiety selected from the group consisting of hydroxyl, carboxyl and amino moieties, and A, B, C and D are independently selected from hydrogen, alkyl, aryl, halogen, amino, aminoalkyl, nitro, alkoxy, hydroxy, carboxy, haloalkyl or haloalkoxy.
Claim 17
Dependent Claim 24 words
A compound as recited in claim 7, wherein said compound is 4,8-dimethyl-7-(carboxymethyloxy) coumarin, wherein n=0, W=CH 2 COOH, B=CH 3 and D=CH 3 .
Claim 18
Dependent Claim 30 words
A compound as recited in claim 7, wherein said compound is 4,8-dimethyl-7-(2-N,N-dimethylaminoethoxy) coumarin, wherein n=0, W=CH 2 CH 2 N(CH 3 ) 2 , B=CH 3 and D=CH 3 .
Claim 19
Dependent Claim 35 words
A compound as recited in claim 7, wherein said compound is 4,8-dimethyl-7-(2-N,N,N-trimethylammonium ethoxy) coumarin iodide, wherein n=0, W=CH 2 CH 2 N(CH 3 ) 3 + I - , B=CH 3 and D=CH 3 .

References Cited (Backward Citations)

US594784A Cited
US4294822A Cited
US4950770A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-05-31 1996-11-30 1997-06-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-05-31 2000-11-30 2001-06-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-05-31 2004-11-30 2005-06-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag